Performance report
Earnings in (Millions)
$20,000
$15,000
$10,000
$5,000
Revenue
Expenses
Net income
Earnings before interest and taxes (EBIT)
Adjusted EBIT
Free cash flow to firm
Free cash flow to equity
($5,000)
2004 2005 2006 2007
Analysis prepared on Tuesday, January 06, 2009.
Earnings adjustments
We avoid GAAP earnings in our valuations because accrual accounting allows an entity to record revenues before cash is collected and record expenses that do not involve payments of cash. Accrual income almost never matches the actual cash generated from operations. As investors we're primarily interested in the actual cash that a company generates from operations free of any form of manipulation.
    To get there we estimate free cash flows to firm first by making a number major adjustments to earnings;
  • We capitalize research and development, accrual accounting requires that R&D be expensed as it occurs, but we recognize and appreciate that results from R&D creates growth. We treat it the same as all other investments by capitalizing it.
    values in Millions
    R&D asset lifetime5 years
    R&D expense$3,512
    R&D amortized$1,675
    R&D asset value$8,638
    The R&D asset value is used to adjust the book value of equity, this in turn is used in the return on equity calculations.
  • True one time charges muddle the growth picture of a stock because they tend to have a significant effect on profit but not earnings from operations. Valuations depend on our ability to predict future earnings growth, to get there we remove one time expenses from earnings.
  • The marginal tax rate is used to determine the taxes that aught to have been paid. Corporations have a number of ways to defer the taxes they pay, these deferments can have a significant impact on stated earnings. Eventually though they have to be paid causing another significant impact on earnings. In order to avoid these oscillations to earnings we use the marginal tax rate to determine the amount paid for taxes.
  • The other major adjustment to earnings that is made is by accounting for off-balance sheet item such as operating leases. Operating leases are treated as Operating expenses where they should be treated as financial expenses that have the same obligations as debt. Our second major adjustment therefore is in converting operating leases to their debt equivalent.
    Operating lease expenses and debt adjustment in (Millions)
    Current year$143
    Year one$116
    Year two$90
    Year three$72
    Year four$71
    Post year four$212
    Total$704
    Debt value$433
    Depreciation$72
    Debt Adjustment
    + Debt$4,381
    + Value of operating lease debt$433
    = Debt (Adjusted)$4,814
This leads to the following adjustments to earnings
Earnings Adjustement (values in Millions)
+ Earning before interest and taxes (EBIT):$2,968
+ R&D expense: $3,512
- R&D amortized: $1,675
+ Operating lease expense: $143
- Operating lease depreciation: $72
+ One time charges: $0
= Adjusted earnings before interest and taxes$4,876
- Taxes ( marginal rate = 35 % ): $1,706
= Adjusted earnings after taxes: $3,169
Now we have a better value for earnings that can be compared year to year to get a better picture of growth.
Cashflow analysis
Free cash flow is the actual cash generated from operations, it is similar in concept to Warren Buffets concept of owner earnings.
It is determined by subtracting from adjusted earnings the amount a company invests in growth. Growth investments include investments in R&D, acquisitions, investments in operations (working capital investment) and investment in fixed capital.
Investment expenses (Millions)
+ R&D investment$3,512
+ Working capital investment$1,390
+ Fixed capital investment$843
+ Acquisitions$415
Investment depreciation and amortization (Millions)
- R&D amortized$1,675
- Fixed capital depreciation$542
- Operating lease depreciation$72
= Reinvested for future growth$3,871
The amount a company reinvests will determine future growth.
Free cash flow to firm derivation: (values in Millions)
+ Adjusted Earnings Before Interest and Taxes (EBIT):$4,876
- Marginal Tax Rate:35.00 %
= Adjusted Earning after taxes:$3,169
- Reinvested$3,871
= Free cash flow to firm (FCFF)($701)
After equity is adjusted to include the R&D asset value and debt to include the Operating lease liabilities debt equivalent, managements effectiveness can be measured more accurately. The below shows the effect the adjustments to earnings have on the returns on capital and equity.
Returns on investment:
Return on capital (ROC)11.19 %
Return on equity (ROE)21.67 %
Adjusted ROC16.76 %
Adjusted ROE25.34 %
A good estimate for future growth is derived by multiplying the estimated future reinvestment rate with the estimated future return on capital.
Operating efficiency
The balance sheet provides insight into the company's operations. It contains all it's assets and liabilities. Of particular interest are it's current assets and liabilities, these are the short term assets and liabilities generated from it's operating activities. For a company that produces a product, for example, the current assets and liabilities are the items that the company uses to build the product such as inventory and raw materials, the money owed the company after selling the product to it's customers and the money it owes to creditors such as the raw material wholesalers as well as service providers. The following metrics are estimates that define how efficient a company is at executing the sales cycle.
  • Days inventory outstanding This metric measures how many days worth of inventory the company has in it's warehouse. It is measured as following DIO = (Inventory/Cost of sales) * 365.
  • Days payable outstandingPayables are the moneys owed to creditors such as the providers of the raw materials or service providers. Days payable outstanding is a measure of how long the company takes to pay its creditors. it is calculated as follows: DPO = (Accounts Payable/ Cost of sales )*365.
  • Days sales outstanding Sales are revenues, receivables are uncollected sales made on credit. A company has to collect sales as quickly as possible so it can use that money to create more products. This value is estimated as following: (Receivables / Revenues) * 365 or ( receivables/ Average sales per day).
  • Cash conversion cycle. This metric measures how quickly in days a company can produce a product from raw materials, sell it to a customer and collect those sales, it is estimated in the following way: CCC = DIO + DSO - DPO. a good way to measure how effective management is at making money is by looking at the cash conversion cycle over time. Warning flags are an increase of Inventory (can't sell product) and Receivables (can't collect on the goods sold on credit)
The following table shows the operating efficiency of BRISTOL MYERS SQUIBB CO
Values in days2007200620052004
Cash conversion cycle1221189464
Days inventory outstanding127127127112
Days payable outstanding857697130
Days sales outstanding80666482
Risk
Risk is an important measure that determines whether a stock is worth investing in and the associated fair value of that stock. The investor loses their entire investment when that company goes bankrupt. The measures below give an indication of bankruptcy risk and needs to be carefully assessed.
  • Current ratio The current ratio is a financial ratio that measures a companies ability to pay it's short term liabilities. When short term liabilities exceed short term assets the current ratio will be less than one and this indicates that a company may have problems meeting it's short-term obligations. It is calculated as follows: Current Ratio = Current Assets / Current Liabilities
  • Acid test or quick ratioT he acid test measures a companies ability to pay it's short term obligations quickly using cash and near cash. It is calculated as follows: Acid Test = (Cash + Investments) / Current Liabilities
  • Acid test (liberal) The more liberal version of the acid test allows a company to collect receivables and other assets except for inventory. Acid test (liberal) = (Current Assets - Inventory) / Current Liabilities
  • Debt to equity ratio The debt to equity ratio shows the proportion of debt and equity used to finance a company's assets. Debt and equity are both adjusted to account for Operating leases and R&D as described above. The debt to equity ratio is calculated by dividing Debt by Equity.
  • Interest coverage ratio The interest coverage ratio measures a firms ability to meet it's interest payments, it is calculated as follows: Interest coverage ratio = EBIT (adjusted) / Interest payment
  • Fixed charges coverage ratio Fixed charges include interest payments and operating lease expenses for this year it is calculated as follows. EBIT (adjusted) / (interest payment + operating lease expense)
The following table shows the risk ratios described above.
Risk ratios2007200620052004
Current ratio1.201.591.781.50
Acid test0.260.620.840.76
Acid test (liberal)0.951.271.481.32
Debt to equity ratio (Adjusted)0.280.510.630.86
Interest coverage ratio (Adjusted)0.000.000.000.00
Fixed charges coverage ratio (Adjusted)34.1034.0250.2152.98
Performance data
Revenue/Earnings data
Historic values
Earnings in (Millions)2007200620052004
Revenue$19,348$17,914$19,207$19,380
Expenses$18,177$16,704$17,081$17,543
Net income$2,165$1,585$3,000$2,388
Earnings before interest and taxes (EBIT)$2,968$2,195$3,932$3,907
Adjusted EBIT$4,876$4,796$6,477$6,517
Free cash flow to firm($701)$644$1,527$1,699
Free cash flow to equity$59$1,572$2,733$2,338
Operating lease expenses
Historic values
Operating lease expense and debt conversion in (Millions)2007200620052004
Current year$143$141$129$123
Year one$116$120$105$99
Year two$90$97$81$78
Year three$72$70$58$65
Year four$71$63$34$62
Post year four$212$223$68$58
Total$704$714$475$485
Debt value$433$454$293$304
Depreciation$72$76$73$76
stock price calculator
Past growth rates
35 %
30 %
25 %
20 %
15 %
10 %
5 %
EBIT (adjusted)
Profit
Revenue
-5 %
-10 %
-15 %
-20 %
all 3 years 2 years
Cashflow in (Millions)
$7,000
$6,000
$5,000
$4,000
$3,000
$2,000
$1,000
Profit
EBIT
FCFE
FCFF
($1,000)
2004 2005 2006 2007
Reinvestment in years past.
( values in Millions )2007200620052004
+ R&D investment$3,512$3,067$2,746$2,563
+ Working capital investment$1,390$155$458
+ Fixed Capital investment$843$785$738$676
+ Acquisitions$415$283
- R&D amortized$1,675$531$256
- Fixed capital depreciation$542$927$929$909
- Operating lease depreciation$72$76$73$76
= Reinvested$3,871$2,473$2,683$2,537
Cashflow adjustments in years past.
( values in Millions )2007200620052004
Adjusted EBIT$4,876$4,796$6,477$6,517
Marginal tax rate35.00 %35.00 %35.00 %35.00 %
Adjusted EBIT(1 - t)$3,169$3,118$4,210$4,236
Reinvestment expense (gain)$3,871$2,473$2,683$2,537
Free cash flow to firm (FCFF)($701)$644$1,527$1,699
The rate of reinvestment in years past.
past reinvestment rates2 years3 yearsall
Reinvestment100.74 %88.40 %81.27 %
Working capital investment24.42 %19.90 %14.93 %
R&D investment104.60 %91.47 %83.73 %
Acquisitions6.55 %4.36 %4.94 %
Net capital investments25.89 %23.10 %21.32 %
Historic growth rates for important measures of earnings.
Past growth rates2 years3 yearsall
EBIT (adjusted)1.64 %-14.88 %-11.66 %
Profit30.93 %-18.56 %-9.12 %
Revenue7.70 %0.37 %-0.73 %
Working capital.
( values in Millions )2007200620052004
Cash and equivalent$1,801$2,018$3,050$3,680
Short term investments$424$1,995$2,749$3,794
Accounts receivable$4,240$3,247$3,378$4,373
Inventory$2,162$2,079$2,060$1,830
Deferred taxes$851$649$776$805
Prepaid expenses$310$314$270$319
Other assets$560
Total assets$10,348$10,302$12,283$14,801
Accounts payable$1,442$1,239$1,579$2,127
Debt payments$1,891$187$231$1,883
Accrued Expenses$2,951$2,332$2,321$2,838
Tax payable$296$444$538$1,023
Other liabilities$2,064$2,294$2,221$1,972
Total liabilities$8,644$6,496$6,890$9,843
Working capital$1,704$3,806$5,393$4,958
Non cash working capital$1,370($20)($175)($633)
Investment in working capital$1,390$155$458
Business Summary
Corporate Information
Executive Officers
EVP & Chief Operating OfficerANDREOTTI LAMBERTO
SVP, Human ResourcesBEAR STEPHEN E
SVP, Strat & Med & Ext AffairsBODNAR ANDREW G
EVP & CFOBONFIELD ANDREW R J
SVP Strat & Productivity TransCelentano John E
VP Strat Bus InitiativesZABOR DAVID L
Former CEODOLAN PETER R
SVP, Corp & Bus DevelopmentHOWSON TAMAR D
EVP, CSO & President R&DSIGAL ELLIOT
Chairman & CEOCORNELIUS JAMES M
SVP and General CounselLEUNG SANDRA
VP & Financial ControllerCaldarella Joseph C
President, Tech OpsCarlo de Notaristefani
EVP & General CounselMCGOLDRICK JOHN L
Vice President & TreasurerDWYER EDWARD M
President US PharmaceuticalsHOOPER ANTHONY C
SVP Corporate AffairsZito Robert T
EVP and President, AmericasHAYDEN DONALD J JR
CMO & Pres, Global MarketingDIXON WENDY L
SVP, Global Reg SciencesWolgemuth Richard L
SVP & General CounselWILLARD RICHARD K
SVP Human ResourcesMCBRIDE ANTHONY A
SVP Global DevelopmentDANIELS BRIAN
SVP & CFOHuet Jean-Marc
Board of Directors
ALLEN ROBERT E
SATO VICKI L
Williams R Sanders
COFFMAN VANCE D
FREEH LOUIS J
GLIMEHER LAURIE H
ROBINSON JAMES D III
DOLAN PETER R
CORNELIUS JAMES M
GROBSTEIN MICHAEL
CAMPBELL LEWIS B
JOHANSSON LEIF
SULLIVAN LOUIS W
GERSTNER LOUIS V JR
GLIMCHER LAURIE H MD
GLIMCHER LAURIE H MD
FUTTER ELLEN V
LACY ALAN J
WEST TOGO D JR
Investors
Other investors
Earnings in (Millions)2007200620052004
Revenue$19,348$17,914$19,207$19,380
Expenses$18,177$16,704$17,081$17,543
Net income$2,165$1,585$3,000$2,388
Earnings before interest and taxes (EBIT)$2,968$2,195$3,932$3,907
Adjusted EBIT$4,876$4,796$6,477$6,517
Free cash flow to firm($701)$644$1,527$1,699
Free cash flow to equity$59$1,572$2,733$2,338
Adjusted debt$4,814$7,702$8,657$8,767
Adjusted equity$17,364$15,044$13,771$10,202
Adjusted depreciation$2,289$1,534$1,259$985
Total reinvestment$3,871$2,473$2,683$2,537
Adjusted EBIT$4,876$4,796$6,477$6,517
Adjusted EBIT(1 - t)$3,169$3,118$4,210$4,236
FCFF($701)$644$1,527$1,699
FCFE$59$1,572$2,733$2,338
Cash conversion cycle1221189464
Days inventory outstanding127127127112
Days payable outstanding857697130
Days sales outstanding80666482
Acid test0.260.620.840.76
liberal acid test0.951.271.481.32
Current ratio1.201.591.781.50
Fixed charges coverage ratio20.7615.5730.4831.76
Interest coverage ratio0.000.000.000.00
 
Current Assets
Cash and equivalent$1,801$2,018$3,050$3,680
Short term investments$424$1,995$2,749$3,794
Accounts receivable$4,240$3,247$3,378$4,373
Inventory$2,162$2,079$2,060$1,830
Deferred taxes$851$649$776$805
Prepaid expenses$310$314$270$319
Other assets$560
Total assets$10,348$10,302$12,283$14,801
 
Current Liabilities
Accounts payable$1,442$1,239$1,579$2,127
Debt payments$1,891$187$231$1,883
Accrued Expenses$2,951$2,332$2,321$2,838
Tax payable$296$444$538$1,023
Other liabilities$2,064$2,294$2,221$1,972
Total liabilities$8,644$6,496$6,890$9,843
Working capital$1,704$3,806$5,393$4,958
Non cash working capital$1,370($20)($175)($633)
Investment in working capital$1,390$155$458
Second Opinions
Write your opinion
Use of this site constitutes acceptance of our User Agreement (c) 2008 EquityHive. L.L.C. All rights reserved.